Nvwm, LLC Novo Cure LTD Transaction History

Nvwm, LLC

$382 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$40.29 - $82.51 $1,369 - $2,805	34 Added 0.49%	6,974 $289,000
Q1 2023 May 11, 2023	SELL	$56.44 - $118.81 $167,231 - $352,034	-2,963 Reduced 29.92%	6,940 $417,000
Q4 2022 Feb 14, 2023	SELL	$63.98 - $85.37 $1,535 - $2,048	-24 Reduced 0.24%	9,903 $726,000
Q3 2022 Nov 15, 2022	SELL	$67.99 - $89.57 $407 - $537	-6 Reduced 0.06%	9,927 $755,000
Q1 2022 May 11, 2022	SELL	$60.15 - $84.52 $9,383 - $13,185	-156 Reduced 1.55%	9,933 $823,000
Q3 2021 Nov 03, 2021	BUY	$116.17 - $194.55 $22,304 - $37,353	192 Added 1.94%	10,089 $1.17 Million
Q2 2021 Aug 04, 2021	SELL	$130.4 - $225.58 $74,197 - $128,355	-569 Reduced 5.44%	9,897 $2.2 Million
Q1 2021 May 11, 2021	SELL	$124.11 - $190.17 $10,301 - $15,784	-83 Reduced 0.79%	10,466 $1.38 Million
Q4 2020 Feb 09, 2021	SELL	$112.16 - $174.14 $94,102 - $146,103	-839 Reduced 7.37%	10,549 $1.83 Million
Q3 2020 Dec 10, 2020	BUY	$58.05 - $111.31 $8,010 - $15,360	138 Added 1.23%	11,388 $1.27 Million
Q2 2020 Aug 11, 2020	SELL	$57.2 - $74.41 $10,467 - $13,617	-183 Reduced 1.6%	11,250 $667,000
Q1 2020 May 08, 2020	BUY	$57.05 - $95.75 $32,974 - $55,343	578 Added 5.32%	11,433 $770,000
Q4 2019 Feb 07, 2020	SELL	$68.3 - $93.8 $24,246 - $33,299	-355 Reduced 3.17%	10,855 $915,000
Q3 2019 Oct 29, 2019	SELL	$61.86 - $97.8 $180,507 - $285,380	-2,918 Reduced 20.65%	11,210 $838,000
Q2 2019 Aug 07, 2019	BUY	$42.22 - $63.23 $36,815 - $55,136	872 Added 6.58%	14,128 $893,000
Q1 2019 May 10, 2019	SELL	$31.96 - $56.12 $165,233 - $290,140	-5,170 Reduced 28.06%	13,256 $639,000
Q4 2018 Jan 29, 2019	BUY	$28.72 - $52.63 $3,877 - $7,105	135 Added 0.74%	18,426 $617,000
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $142,016 - $232,551	-4,438 Reduced 19.53%	18,291 $958,000
Q2 2018 Aug 01, 2018	BUY	$19.85 - $32.0 $216,146 - $348,448	10,889 Added 91.97%	22,729 $711,000
Q1 2018 May 17, 2018	BUY	$19.3 - $23.65 $10,460 - $12,818	542 Added 4.8%	11,840 $241,000
Q4 2017 Mar 15, 2018	BUY	$16.3 - $21.9 $184,157 - $247,426	11,298	11,298 $228,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$374 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$365 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$244 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$133 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$93.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvwm, LLC with notifications on news.

Account